Randomized controlled trial to evaluate anti-mycobacterial effects of Hochhu-ekkito add-on therapy for patients with pulmonary Mycobacterium avium complex disease intractable with or intolerant to conventional treatmnt
Not Applicable
- Conditions
- Pulmonary Mycobacterium avium complex disease
- Registration Number
- JPRN-UMIN000009920
- Lead Sponsor
- Kanagawa Cardiovascular and Respiratory Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with any malignant diseases (2) Patients with interstitial lung diseases (3) Patients whose regimen for anti-mycobacterai therapy had been changed within three months (4) Patients who had been receiving any herbal drugs including Hochu-ekkito within three months (5) Patients with severe other pulmonary diseases (6) Pregnant women or females with childbearing potential (7) Any other condition which, in the opinion of the investigator, would make the subject unsuitable for enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method